Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/1820
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOlorunsogo, O.O-
dc.contributor.authorBbbabunmi, E.-
dc.date.accessioned2022-01-28T16:16:23Z-
dc.date.available2022-01-28T16:16:23Z-
dc.date.issued1992-
dc.identifier.citationAfri J Med Med Sci 1992, 21(1): 17-21en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/1820-
dc.description.abstractNifedipine, a 1,4-dihydropyridine Ca2+ -channel blocker inliibits calmodulin-stimulated activity of erytlirocyte plasma membrane (Ca 2 + + Mg2 + ) -ATPase. Its inhibition of the basal activity of the enzyme increases on pre-incubation with membranes. The maximum velocity, affinity for ATP and Ca 2+ -sensitivity of pump are reduced by micromolar amounts of the antihypertensive drug. These results suggest that 1,4-dihydropyridines may interact with calcium-binding proteins and calcium-dependent enzymes at their calciumbinding sites.en_US
dc.description.sponsorshipCollege of Medicine, University of Ibadan, Nigeria.en_US
dc.language.isoenen_US
dc.publisherSpectrum Books Limiteden_US
dc.subjectEnzymeen_US
dc.subjectErytlirocyte plasma membrane (Ca 2 + + Mg2 + ) -ATPaseen_US
dc.subjectNifedipine, a 1,4-dihydropyridine Ca2+ -channel blockeren_US
dc.titleCalmodulin antagonism and inhibition of erythrocyte plasma membrane Ca + -pump by nifedipine, a calcium channel blockeren_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Olorunsogo-Bababunmi_Calmodulin_1992.pdfArticle11.81 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.